Published in Healthcare Mergers, Acquisitions and Ventures Week, October 6th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Response Genetics, Inc.
Report 1: Response Genetics, Inc. (NASDAQ:RGDX) announced that Company President and Chief Executive Officer Kathleen Danenberg will speak about cancer biomarkers and highlight Company data in colorectal, lung and pancreatic cancer at the Twenty-Second Aspen Cancer Conference Satellite Meeting, New Frontiers In Clinical Oncology 2007, in Aspen, Colorado, on Friday, July 20, at 8:50 a.m. Mountain Daylight Time. These data show that the Company's proprietary and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.